Signed an agreement with Sanofi Pasteur to license out cell-culture technology for producing cell culture-derived influenza vaccines. Established SK Bioscience. Launched Sky Zoster Inj., world’s second shingles vaccine
Signed an agreement with international organization PATH to develop and produce pediatric enteritis vaccine for developing countries Launched SKYCellflu Quadrivalent, world’s first quadrivalent cell culture...
Signed an agreement with Sanofi Pasteur to license out cell-culture technology for producing cell culture-derived influenza vaccines. Established SK Bioscience. Launched Sky Zoster Inj., world’s second shingles vaccine
Signed an agreement with international organization PATH to develop and produce pediatric enteritis vaccine for developing countries Launched SKYCellflu Quadrivalent, world’s first quadrivalent cell culture-derived influenza vaccine. Gained approval for SKYPNEUMO, the first domestically produced PCV13 vaccine. Launched SKYCellflu, Korea’s first trivalent cell culture-derived influenza vaccine
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.